Response to transplantation according to GVHD development
| . | Yes . | No . | P . |
|---|---|---|---|
| Acute GVHD | |||
| Response to transplantation | |||
| CR/PR | 16 (55.2%) | 26 (29.5%) | .025 |
| Stable/progression | 13 (44.8%) | 56 (70.5%) | |
| Disease status at last follow-up4-150 | |||
| CR/PR | 21 (75%) | 47 (67.1%) | .61 |
| Stable/progression | 7 (25%) | 23 (32.9%) | |
| Chronic GVHD | |||
| Response to transplantation | |||
| CR/PR | 17 (74%) | 23 (29%) | .016 |
| Stable/progression | 6 (23%) | 57 (71%) |
| . | Yes . | No . | P . |
|---|---|---|---|
| Acute GVHD | |||
| Response to transplantation | |||
| CR/PR | 16 (55.2%) | 26 (29.5%) | .025 |
| Stable/progression | 13 (44.8%) | 56 (70.5%) | |
| Disease status at last follow-up4-150 | |||
| CR/PR | 21 (75%) | 47 (67.1%) | .61 |
| Stable/progression | 7 (25%) | 23 (32.9%) | |
| Chronic GVHD | |||
| Response to transplantation | |||
| CR/PR | 17 (74%) | 23 (29%) | .016 |
| Stable/progression | 6 (23%) | 57 (71%) |
Disease status after CsA taper and DLI.